🇺🇸 FDA
Patent

US 11382899

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

granted A61KA61K31/436A61K38/13

Quick answer

US patent 11382899 (Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery) held by The Board of Regents of the University of Texas System expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/436, A61K38/13, A61K9/0075, A61K9/0078